Olmesartan/Amlodipin/ Hct Accord (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin/ Hct Accord, is a angiotensin II receptor blocker presented as a combination tablet for oral use. It treats hypertension, often in combination with other antihypertensive agents, and is suitable for adult patients. GNH USA supplies Olmesartan/Amlodipin/ Hct Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan/Amlodipin/ Hct Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan/Amlodipin/ Hct Accord is used primarily as an antihypertensive regimen that targets multiple pathways involved in blood pressure regulation.

- Hypertension: helps reduce systolic and diastolic blood pressure in adults. - Heart failure with reduced ejection fraction: supports blood‑pressure control as part of a broader therapeutic plan. - Diabetic nephropathy : provides additional blood‑pressure lowering to protect renal function in patients with type 2 diabetes. - Chronic kidney disease : assists in maintaining stable blood pressure to slow progression of renal damage. - Post‑    

The